156 related articles for article (PubMed ID: 28126478)
21. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells.
Fan WH; Du FJ; Liu XJ; Chen N
Oncol Rep; 2016 Nov; 36(5):2999-3004. PubMed ID: 27666874
[TBL] [Abstract][Full Text] [Related]
23. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
[No Abstract] [Full Text] [Related]
25. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.
Luke JJ; Bao R; Sweis RF; Spranger S; Gajewski TF
Clin Cancer Res; 2019 May; 25(10):3074-3083. PubMed ID: 30635339
[TBL] [Abstract][Full Text] [Related]
26. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
27. MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway.
Lu C; Jia S; Zhao S; Shao X
Cancer Biomark; 2019; 25(1):115-126. PubMed ID: 31006667
[TBL] [Abstract][Full Text] [Related]
28. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
Wong CM; Fan ST; Ng IO
Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619
[TBL] [Abstract][Full Text] [Related]
29. Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.
Debebe A; Medina V; Chen CY; Mahajan IM; Jia C; Fu D; He L; Zeng N; Stiles BW; Chen CL; Wang M; Aggarwal KR; Peng Z; Huang J; Chen J; Li M; Dong T; Atkins S; Borok Z; Yuan W; Machida K; Ju C; Kahn M; Johnson D; Stiles BL
Oncogene; 2017 Oct; 36(43):6020-6029. PubMed ID: 28671671
[TBL] [Abstract][Full Text] [Related]
30. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
[TBL] [Abstract][Full Text] [Related]
31. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?
Corbin M; de Reyniès A; Rickman DS; Berrebi D; Boccon-Gibod L; Cohen-Gogo S; Fabre M; Jaubert F; Faussillon M; Yilmaz F; Sarnacki S; Landman-Parker J; Patte C; Schleiermacher G; Antignac C; Jeanpierre C
Genes Chromosomes Cancer; 2009 Sep; 48(9):816-27. PubMed ID: 19530245
[TBL] [Abstract][Full Text] [Related]
32. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
34. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
35. Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort.
Sandow T; Pavlus J; Field D; Lacayo E; Cohen E; Lynskey G; Caridi T; Buckley D; Cardella J; Kallakury B; Spies J; Kim AY
J Vasc Interv Radiol; 2019 Jul; 30(7):995-1003. PubMed ID: 31109853
[TBL] [Abstract][Full Text] [Related]
36. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
37. Wnt signalling is a bi-directional vulnerability of cancer cells.
Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891
[TBL] [Abstract][Full Text] [Related]
38. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
39. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
[TBL] [Abstract][Full Text] [Related]
40. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
